IND
Beyond's analysis on IND
- — AbelZeta regains global rights to C‑CAR039 (Prizlon‑cel) and secures FDA IND clearance for large B‑cell lymphoma therapy
- — Atrium Therapeutics advances its cardiovascular pipeline with IND clearance for ATR 1072 and milestone payment from Bristol Myers Squibb collaboration
- — ArkBio secures China IND approval for long-acting antiviral AK0406, advancing influenza prophylaxis development
- — RiboX Therapeutics secures FDA IND clearance for RXIM002, the world's first circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias, enabling Phase 1 trial initiation
- — Harbour BioMed and Kelun-Biotech secure NMPA IND clearance for HBM7575/SKB575, advancing a novel asthma biologic into clinical trials in China
Recent news mentioning IND
- — +++ USA +++: Mindestens fünf Tote bei Absturz von Amazon-Frachtflugzeug in Miami
- — Pampa Energía Founder Marcos Mindlin Buys 150,000 Shares for $507,000. Is This a Signal for Investors to Also Buy?
- — Russia Vows to Keep Selling Oil to India Despite U.S. Tariff Threat
- — India Ramps Up Rail Coal Deliveries as Power Plant Stockpiles Dwindle
- — Grindr to pay £26m to settle claims it allegedly shared users' HIV status
- — Solana Is Up 40% in a Month and XRP 39%. Which Rally Has More Behind It?
- — HelloNation Explains Fire Extinguisher Inspection Indiana Standards With Insights From Fire Protection Expert Jeff Long
- — Hyundai India to invest Rs450bn, launch 26 models by 2030 – report
- — Größter Hafen der Welt: Das sind die weltweit führenden Containerhäfen
- — Most People Asking "What Should I Invest In?" Are Overthinking It. Start With Index Funds and These 4 Stocks.
- — Windows-Rechner in Gefahr: Nach Berliner Cyberangriff: Seien Sie bei Captchas wachsam
- — De la industria al hogar: TCL presenta su visión energética integral en IFA 2026